Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wang-Shi-Bao-Chi-Wan for infantile functional dyspepsia syndrome
ChiCTR2300072543Phase 4Completed
- Sponsor
- Guangzhou Women and Children's Medical Center
- Start
- Jul 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Wangshi Baochi Wan in functional dyspepsia (FD) (2 arms), sponsored by Guangzhou Women and Children's Medical Center. Primary endpoint: Comprehensive effective rate of dyspepsia symptoms. Started Jul 2021; status: completed.
02
Drugs
Wangshi Baochi Wan
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on ChiCTR2300072543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072543.